The modern organizational principles of specialized medical care for pregnant and puerperant women during the coronavirus pandemic in the Republic of Kazakhstan


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The COVID-19 pandemic sweeping around the world has demanded the introduction of emergency lock-down measures, suspended the operation of enterprises, and led to the development of a systemic economic crisis. In a number of countries where governments have taken austerity preventive anti-epidemic measures, the situation could be controlled and a large number of viral infection victims could be prevented. The obstetric service has always been an area of increased responsibility for the life and health of the mother and her child. Each country has operating algorithms, protocols, standards, and guidelines. However, during the epidemic, it can be dangerous to implement the entire package of measures and procedures in the context of COVID-19 infection due to the need to visit outpatient and inpatient healthcare facilities and laboratories. Algorithms for managing pregnancy and childbirth are of particular importance during a viral pandemic. The paper gives an algorithm for the management of pregnant, parturient, and puerperant women with COVID-19 in the Republic of Kazakhstan. The algorithm has been elaborated by the authors on the basis of the experience of the countries that previously faced a true pandemic (China, Italy, and Spain). Along with the traditionally existing orders and recommendations, this algorithm has been introduced in women’s clinics and obstetric hospitals of various regionalization levels in order to preventatively respond to an increase in the number of COVID-19 cases and carriers among pregnant parturient, and puerperant women. In the Republic of Kazakhstan, as of September 1, 2020 COVID-19 cases were registered in 4851 women, of whom there were 3473 pregnant women and 1378 postpartum ones. Spontaneous childbirth occurred in 1247 (90.5%) women; caesarean section was performed in 131 (9.5%) cases. COVID-19 was confirmed in 124 (8.75%) of the 1,420 newborns; of whom 1116 (78.57%) infants were born to puerperas with the confirmed diagnosis and 304 (21.43%) were born to mothers with a negative COVID-19 test.

Full Text

Restricted Access

About the authors

Vyacheslav N. Lokshin

PERSONA International Clinical Center for Reproductology, Almaty

Email: vjokshin@persona-ivf.kz
MD, professor, academician of the National Academy of Sciences of the Republic of Kazakhstan, president of the Kazakhstan Association of Reproductive Medicine; Director General

Almaz T. Sharman

Academy of Preventive Medicine, Almaty

Email: asharman@zdrav.kz
MD, professor, President

Dinara D. Mirzakhmetova

Research Center of Obstetrics, Gynecology, and Perinatology, Almaty

Email: d.mirzakhmetova@mail.ru
obstetrician-gynecologist of the highest category

Aigul T. Terlikbaeva

Research Center of Obstetrics, Gynecology, and Perinatology, Almaty

Email: aigultrk@mail.ru
candidate of medical sciences, PhD, obstetrician-gynecologist of the highest category, Deputy for Science and Strategy

Aliya R. Aimbetova

Research Center of Obstetrics, Gynecology, and Perinatology, Almaty

Email: aaimbetova@inbox.ru
MD, obstetrician-gynecologist of the highest category, Deputy for Clinical Activities

Sholpan K. Karibaeva

PERSONA International Clinical Center for Reproductology, Almaty

Email: sh.karibaeva@gmail.com
PhD, obstetrician-gynecologist, reproductologist of the highest category, strategic development director

Kymbat A. Urazymbetova

PERSONA International Clinical Center for Reproductology, Almaty

Email: dr.urazymbetova@gmal.com
obstetrician-gynecologist, reproductologist

References

  1. Huang C., Wang Y, Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. https://dx.doi.org/10.1016/S0140-6736(20)30183-5.
  2. Chen N., Zhou M, Dong X, Qu J., Gong F., Han Y. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507-13. https:// dx.doi.org/10.1016/S0140-6736(20)30211-7.
  3. Liu Y, Gayle A.A., Wilder-Smith A., Rocklov J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med. 2020; 27(2): taaa021. https://dx.doi.org/10.1093/jtm/taaa021.
  4. Hoffmann M., Kleine-WeberH., Kruger N., MullerM., Drosten C., Pohlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. 2020: 2020.01.31. 929042. https://dx.doi.org/10.1101/2020.01.31.929042. Available at: https://www.biorxiv.org/content/10.1101/2020.01.31.929042v1
  5. World Health Organization. Critical preparedness, readiness and responsactions for COVID-19. Interim guidance. 7 March 2020. Available at: https://www.who. int/docs/default-source/coronaviruse/20200307-cccc-guidance-table-covid-19-final pdf?sfvrsn=1c8ee193_10
  6. Drews FA., Mulvey D., Stratford K., Samore M.H., Mayer J. Evaluation of a redesigned personal protective equipment gown. Clin. Infect. Dis. 2019; 69(Suppl. 3): S199-205. https://dx.doi.org/10.1093/ cid/ciz520.
  7. Fineberg H.V. Ten weeks to crush the curve. N. Engl. J. Med. 2020; 382(17): e37. https://dx.doi.org/10.1056/NEJMe2007263.
  8. Cohen J., Vignaux O., Jacquemard F. Covid-19 in pregnant women: general data from a French National Survey. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; 251: 267-8. https://dx.doi.org/10.1016/j.ejogrb.2020.06.002.
  9. Kampf G., Todt D., Pfaender S., Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J. Hosp. Infect. 2020; 104(3): 246-51. https://dx.doi.org/10.1016/j. jhin.2020.01.022.
  10. Chen L., Li Q., Zheng D., Jiang H., Wei Y., Zou L. et al. Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. N. Engl. J. Med. 2020; 382(25): e100. https://dx.doi.org/10.1056/NEJMc2009226.
  11. Liu D., Li L., Wu X., Zheng D., Wang J., Yang L. et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am. J. Roentgenol. 2020; 215(1): 127-32. https:// dx.doi.org/10.2214/AJR.20.23072.
  12. World Health Organization, 2020. CC BY-NC-SA 3.0 IGO. Available at: https://www.euro.who.int/__data/assets/pdf_file/0009/439749/breastfeeding-COVID-19-rus.pdf
  13. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)», версия 3 (3 марта 2020г.) (утвержденные Министерством здравоохранения РФ). [Temporary guidelines "Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)", version 3 (03.03.2020), approved. Ministry of Health of Russia]. Available at: http://www.consultant.ru/document/cons_doc_LAW_347896/
  14. Accelerated emergency use authorization (EUA) Summary. SARS-cov-2 ASSAY Apr 20, 2020. Available at: https://www.fda.gov/media/136875/ download https://novayagazeta.ru/articles/2020/03/25/84505-kakoy-covid-otkryvaetsya-iz-nashego-okna
  15. Van Doremalen N., Bushmaker T., Morris D.H., Holbrook M.G., Gamble A., Williamson B.N. et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 2020; 382(16): 1564-7. https://dx.doi. org/10.1056/NEJMc2004973.
  16. Mackay I.M., Arden K.E. MERS coronavirus: diagnostics, epidemiology and transmission. Virol. J. 2015; 12: 222. https://dx.doi.org/10.1186/s12985-015-0439-5.
  17. Lazzerini M., Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. Lancet Glob. Health. 2020; 8(5): e641-2. https://dx.doi. org/10.1016/S2214-109X(20)30110-8.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies